Sign inJoin waitlistJoin the waitlist

HL

Heather Landau

Director, Amyloidosis Program · New York Presbyterian Hospital

Credentials: · · ·

History

Amyloidosis Program · New York Presbyterian Hospital
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2004–2007
Internal Medicine
University of Colorado School of Medicine
2001–2004
State University of New York Upstate Medical University
1997–2001

Research

Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
Review · Leukemia · 2012 · 316 citations
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Journal of Clinical Oncology · 2019 · 217 citations

SG
Sergio Giralt
99 papers
HH
Hani Hassoun
76 papers
AL
Alexander Lesokhin
65 papers
Gunjan Shah
61 papers
DC
David Chung
60 papers
SM
Sham Mailankody
57 papers · 7 as a fellow
Michael Scordo
55 papers
NK
Neha Korde
51 papers
Saad Usmani
45 papers
MH
Malin Hultcrantz
44 papers
Urvi Shah
42 papers · 3 as a fellow
Oscar Lahoud
38 papers · 1 as a fellow

Clinical trials

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2023–2029
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2018–2026
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2016–2026
Pilot Trial of Homebound Stem Cell Transplantation
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2016–2027